首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12篇
  免费   1篇
理论与方法论   1篇
现状及发展   4篇
综合类   8篇
  2017年   1篇
  2014年   1篇
  2007年   2篇
  2006年   1篇
  2003年   2篇
  1998年   2篇
  1995年   1篇
  1993年   1篇
  1992年   1篇
  1987年   1篇
排序方式: 共有13条查询结果,搜索用时 78 毫秒
11.
The eosinophil ribonucleases, eosinophil-derived neurotoxin (EDN/RNase 2) and eosinophil cationic protein (ECP/RNase 3) are two closely related proteins with intriguing functional and evolutionary properties. While both EDN and ECP maintain the structural and catalytic residues typical of the RNase A superfamily, the role of ribonuclease activity in the physiologic function of these proteins remains unclear. The biochemistry and physiology of EDN, ECP and the recently discovered ribonuclease k6 (RNase 6) will be reviewed in this chapter.  相似文献   
12.
生境破碎化对非人灵长类生存影响的研究   总被引:1,自引:0,他引:1  
生境破碎化是生物多样性研究的热点之一.综合论述了生境破碎化的概念、成因和以景观生态学、异质种群学说、岛屿生物地理学组成的理论基础,并着重论述了生境破碎化对非人灵长类的影响现状.  相似文献   
13.
Towards progress on DNA vaccines for cancer   总被引:2,自引:0,他引:2  
Cancer immunotherapy faces many obstacles that include eliciting immune reactions to self antigens as well as overcoming tumor-derived immunosuppressive networks and evasion tactics. Within the vaccine arsenal for inhibiting cancer proliferation, plasmid DNA represents a novel immunization strategy that is capable of eliciting both humoral and cellular arms of the immune response in addition to being safely administered and easily engineered and manufactured. Unfortunately, while DNA vaccines have performed well in preventing and treating malignancies in animal models, their overall application in human clinical trials has not impacted cancer regression to date. Since the establishment of these early trials, progress has been made in terms of increasing DNA vaccine immunogenicity and subverting the suppressive properties of tumor cells. Therefore, the success of future plasmid DNA use in cancer patients will depend on combinatorial strategies that enhance and direct the DNA vaccine immune response while also targeting tumor evasion mechanisms. Received 2 April 2007; received after revision 14 May 2007; accepted 21 May 2007  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号